The Combination of Preoperative Nutritional Risk Screening-2002 and Neutrophil-to-Lymphocyte Ratio is a Useful Prognostic Marker in Patients with Esophageal Squamous Cell Carcinoma

References

• Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108. doi:10.3322/caac.21262
   PubMed Web of Science ®Google Scholar
• Lin Y, Totsuka Y, He Y, Kikuchi S, Qiao Y, Ueda J, Wei W, Inoue M, Tanaka H. Epidemiology of esophageal cancer in Japan and China. J Epidemiol. 2013;23(4):233–42. doi:10.2188/jea.je20120162
   PubMed Web of Science ®Google Scholar
• Liu J, Xie X, Zhou C, Peng S, Rao D, Fu J. Which factors are associated with actual 5-year survival of oesophageal squamous cell carcinoma? Eur J Cardiothorac Surg. 2012;41(3):e7–11. doi:10.1093/ejcts/ezr240
   PubMed Web of Science ®Google Scholar
• Wu N, Chen G, Li H, Pang L, Chen Z. Low pretherapeutic serum albumin as a risk factor for poor outcome in esophageal squamous cell carcinomas. Nutr Cancer. 2015;67(3):481–5. doi:10.1080/01635581.2015.1004726
   PubMed Web of Science ®Google Scholar
• Watanabe M, Ishimoto T, Baba Y, Nagai Y, Yoshida N, Yamanaka T, Baba H. Prognostic impact of body mass index in patients with squamous cell carcinoma of the esophagus. Ann Surg Oncol. 2013;20(12):3984–91. doi:10.1245/s10434-013-3073-8
   PubMed Web of Science ®Google Scholar
• Yoshida N, Harada K, Baba Y, Kosumi K, Iwatsuki M, Kinoshita K, Nakamura K, Sakamoto Y, Miyamoto Y, Karashima R, et al. Preoperative controlling nutritional status (CONUT) is useful to estimate the prongnosis after esophagectomy for esophageal cancer. Langenbecks Arch Surg. 2017;402(2):333–41.: doi:10.1007/s00423-017-1553-1
   PubMed Web of Science ®Google Scholar
• Detsky AS, McLaughlin JR, Baker JP, Johnston N, Whittaker S, Mendelson RA, Jeejeebhoy KN. What is subjective global assessment of nutritional status? JPEN J Parenter Enteral Nutr. 1987;11(1):8–13. doi:10.1177/014860718701100108
   PubMed Web of Science ®Google Scholar
• Vellas B, Villars H, Abellan G, Soto ME, Rolland Y, Guigoz Y, Morley JE, Chumlea W, Salva A, Rubenstein LZ, et al. Overview of the MNA—its history and challenges. J Nutr Health Aging. 2006;10(6):456–63.
   PubMed Web of Science ®Google Scholar
• Kondrup J, Rasmussen HH, Hamberg O, Stanga Z. Ad hoc ESPEN working group: nutritional risk screening NRS 2002: a new method based on an analysis of controlled clinical trials. Clin. Nutr. 2003;22(3):321–36. doi:10.1016/S0261-5614(02)00214-5
   PubMed Web of Science ®Google Scholar
• Kondrup J, , Allison SP, Elia M, Vellas B, Plauth M. Educational and Clinical Practice Committee, European Society of Parenteral and Enteral Nutrition (ESPEN). ESPEN guidelines for nutrition screening 2002. Clin Nutr. 2003;22(4):415–21. doi:10.1016/s0261-5614(03)00098-0
   PubMed Web of Science ®Google Scholar
• Njolstad TS, Engerud H, Werner HM, Salvesen HB, Trovik J. Preoperative anemia, leukocytosis and thrombocytosis identify aggressive endometrial carcinomas. Gynecol Oncol. 2013;131(2):410–5. doi:10.1016/j.ygyno.2013.08.032
   PubMed Web of Science ®Google Scholar
• Rassouli A, Saliba J, Castano R, Hier M, Zeitouni AG. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma. Head Neck. 2015;37(1):103–10. doi:10.1002/hed.23567
   PubMed Web of Science ®Google Scholar
• Kozak M, Pai J, Von Eyben R, Anderson E, Koong A, Chang DT. The prognostic significance of pretreatment hematologic parameters in patients undergoing resection for colorectal cancer. Am J Clin Oncol. 2014;90(1):S397. doi:10.1016/j.ijrobp.2014.05.1268
   Google Scholar
• Absenger G, Szkandera J, Pichler M, Stotz M, Arminger F, Weissmueller M, Schaberl-Moser R, Samonigg H, Stojakovic T, Gerger A, et al. A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients. Br J Cancer. 2013;109(2):395–400.: doi:10.1038/bjc.2013.346
   PubMed Web of Science ®Google Scholar
• Koh C-H, Bhoo-Pathy N, Ng K-L, Jabir RS, Tan G-H, See M-H, Jamaris S, Taib NA. Utility of pre-treatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio as prognostic factors in breast cancer. Br J Cancer. 2015;113(1):150–8. doi:10.1038/bjc.2015.183
   PubMed Web of Science ®Google Scholar
• Xu AM, Huang L, Zhu L, Wei ZJ. Significance of peripheral neutrophil-lymphocyte ratio among gastric cancer patients and construction of a treatment-predictive model: a study based on 1131 cases. Am J Cancer Res. 2014;4(2):189–95.
   PubMed Web of Science ®Google Scholar
• Xie X, Luo KJ, Hu Y, Wang JY, Chen J. Prognostic value of preoperative platelet–lymphocyte and neutrophil–lymphocyte ratio in patients undergoing surgery for esophageal squamous cell cancer. Dis Esophagus. 2016;29(1):79–85. doi:10.1111/dote.12296
   PubMed Web of Science ®Google Scholar
• Kano S, Homma A, Hatakeyama H, Mizumachi T, Sakashita T, Kakizaki T, Fukuda S. Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer. Head Neck. 2017;39(2):247–53. doi:10.1002/hed.24576
   PubMed Web of Science ®Google Scholar
• Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K. Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer. 2013;109(2):401–7. doi:10.1038/bjc.2013.350
   PubMed Web of Science ®Google Scholar
• Guo J, Chen S, Chen Y, Li S, Xu D. Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer. Cancer Manage Res. 2018;10:315–21. doi:10.2147/CMAR.S156071
   PubMed Web of Science ®Google Scholar
• Rice TW, Blackstone EH, Rusch VW. 7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction. Ann Surg Oncol. 2010;17(7):1721–4. doi:10.1245/s10434-010-1024-1
   PubMed Web of Science ®Google Scholar
• Liu X, Qiu H, Kong P, Zhou Z, Sun X. Gastric cancer, nutritional status, and outcome. OncoTargets Ther. 2017;10:2107–14. doi:10.2147/OTT.S132432
   PubMed Web of Science ®Google Scholar
• Li J, Cheng Y, Liu G, Ji Z. The association of pretreatment serum albumin with outcomes in bladder cancer: a meta-analysis. OncoTargets Ther. 2018;11:3449–59. doi:10.2147/OTT.S162066
   PubMed Web of Science ®Google Scholar
• Bauer J, Capra S, Ferguson M. Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56(8):779–85. doi:10.1038/sj.ejcn.1601412
   PubMed Web of Science ®Google Scholar
• Zitvogel L, Tesniere A, Kroemer G. Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol. 2006;6(10):715–27. doi:10.1038/nri1936
   PubMed Web of Science ®Google Scholar
• Nowarski R, Gagliani N, Huber S, Flavell RA. Innate immune cells in inflammation and cancer. Cancer Immunol Res. 2013;1(2):77–84. doi:10.1158/2326-6066.CIR-13-0081
   PubMed Web of Science ®Google Scholar
• Kusumanto YH, Dam WA, Hospers GA, Meijer C, Mulder NH. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003;6(4):283–7. doi:10.1023/B:AGEN.0000029415.62384.ba
   PubMedGoogle Scholar
• Titu LV, Monson JR, Greenman J. The role of CD8(+) T cells in immune responses to colorectal cancer. Cancer Immunol Immunother. 2002;51(5):235–47. doi:10.1007/s00262-002-0276-4
   PubMed Web of Science ®Google Scholar